.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085738

« Back to Dashboard
NDA 085738 describes BETAMETHASONE SODIUM PHOSPHATE, which is a drug marketed by Watson Labs and is included in one NDA. Additional details are available on the BETAMETHASONE SODIUM PHOSPHATE profile page.

The generic ingredient in BETAMETHASONE SODIUM PHOSPHATE is betamethasone sodium phosphate. There are sixty-five drug master file entries for this compound. Additional details are available on the betamethasone sodium phosphate profile page.

Summary for NDA: 085738

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 3MG BASE/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc